Chip Baird | Chief Financial Officer
bluebird bio

Chip Baird, Chief Financial Officer, bluebird bio

Chip Baird joined bluebird in February of 2019 as chief financial officer. Chip has over 20 years of financial and strategic planning experience in the biopharmaceutical sector. Prior to bluebird, he served as CFO of Amicus Therapeutics for seven years and spent 10 years as CFO of PTC Therapeutics with responsibility for all areas of finance, investor and public relations, human resources, facilities and project management. Chip also worked in the life science practice at L.E.K. Consulting, a strategy consulting firm, and began his career at First Union National Bank in corporate debt underwriting. Chip currently serves as a Director of Axcella Health. Chip received a B.S. from Georgetown University?s Edmund A. Walsh School of Foreign Service and an M.B.A. in finance from The Wharton School of the University of Pennsylvania.


Day 1: Wednesday 19th May 2021 - Cell Therapy @ 11:30

Keynote panel discussion: State of the industry panel

  • How have events over the last 12 months affected the industry? Maintaining
  • Where is the ATMP field headed?
  • Who is making the best progress?
  • What is new on the market?
  • The Next Wave: moving beyond CAR-T and Gene Therapy, what’s next?
last published: 10/May/21 08:45 GMT

back to speakers